3.69
0.06 (1.52%)
Penutupan Terdahulu | 3.63 |
Buka | 3.69 |
Jumlah Dagangan | 43,479 |
Purata Dagangan (3B) | 232,800 |
Modal Pasaran | 170,029,584 |
Harga / Jualan (P/S) | 5.20 |
Harga / Buku (P/B) | 11.67 |
Julat 52 Minggu | |
Tarikh Pendapatan | 7 May 2025 |
Margin Keuntungan | -15.10% |
Margin Operasi (TTM) | -12.92% |
EPS Cair (TTM) | -0.120 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 17.50% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 22.83% |
Nisbah Semasa (MRQ) | 2.44 |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.05 M |
Pulangan Atas Aset (ROA TTM) | -13.09% |
Pulangan Atas Ekuiti (ROE TTM) | -29.87% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Instruments & Supplies (US) | Bercampur | Menurun |
Medical Instruments & Supplies (Global) | Menurun | Menurun | |
Stok | KORU Medical Systems, Inc. | Menurun | Menurun |
AISkor Stockmoo
Konsensus Penganalisis | -2.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | 4.0 |
Purata | 0.63 |
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). |
|
Sektor | Healthcare |
Industri | Medical Instruments & Supplies |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 7.65% |
% Dimiliki oleh Institusi | 51.77% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
01 Aug 2025 | Pengumuman | KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
30 Jul 2025 | Pengumuman | KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference |
16 Jul 2025 | Pengumuman | KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025 |
07 Jul 2025 | Pengumuman | KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer |
11 Jun 2025 | Pengumuman | KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |